PlainRecalls
FDA Drug Low Class III Terminated

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

Reported: February 13, 2013 Initiated: May 31, 2012 #D-156-2013

Product Description

Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2

Reason for Recall

Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.

Details

Units Affected
138,505 vials
Distribution
Nationwide
Location
Lynnwood, WA

Frequently Asked Questions

What product was recalled?
Leukine sargramostim 5 x 500 mcg/mL vial, liquid injection, Sterile Rx only, Mfd by: Bayer HealthCare Pharmaceuticals, LLC Seattle, WA 98101 U.S. Lic. No. 1791 NDC 58468-0181-2. Recalled by Bayer HealthCare Pharmaceuticals Inc.. Units affected: 138,505 vials.
Why was this product recalled?
Impurities/Degradation Products: A confirmed out of specification result for Leukine sargramostin lot B18827 occurred at the three month time point.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 13, 2013. Severity: Low. Recall number: D-156-2013.